Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 18.71 USD 1.19% Market Closed
Market Cap: 608.8m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

Capricor Therapeutics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Capricor Therapeutics Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Capricor Therapeutics Inc
NASDAQ:CAPR
Accrued Liabilities
$792.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.2B
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$13.7B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.9B
CAGR 3-Years
26%
CAGR 5-Years
22%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Capricor Therapeutics Inc's Accrued Liabilities?
Accrued Liabilities
792.7k USD

Based on the financial report for Jun 30, 2024, Capricor Therapeutics Inc's Accrued Liabilities amounts to 792.7k USD.

What is Capricor Therapeutics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
19%

Over the last year, the Accrued Liabilities growth was 12%.

Back to Top